(Q34147541)

31 July 2017

title

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults (English)

1 reference

treatment-resistant depression

31 July 2017

main subject

1 reference

inferred from title

author

Charles F. Reynolds III

series ordinal

8

object named as

Charles F Reynolds

1 reference

31 July 2017

7

Benoit H Mulsant

1 reference

31 July 2017

5

Eric J Lenze

1 reference

31 July 2017

2

Meryl A Butters

1 reference

31 July 2017

3

Amy E Begley

1 reference

31 July 2017

Jordan F Karp

1

1 reference

31 July 2017

Mark D Miller

series ordinal

4

1 reference

31 July 2017

Daniel M Blumberger

series ordinal

6

1 reference

31 July 2017

publication date

1 August 2014

1 reference

The Journal of Clinical Psychiatry

31 July 2017

published in

1 reference

31 July 2017

volume

75

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

e785-93

1 reference

Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Detecting age differences in resistance to perceptual and motor interference

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Psychotherapeutic benefits of opioid agonist therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

The Clinical Opiate Withdrawal Scale (COWS).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Depression, IV: STAR*D treatment trial for depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Buprenorphine treatment of refractory depression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Development and validation of brief measures of positive and negative affect: The PANAS scales

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Depressive symptoms during buprenorphine treatment of opioid abusers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Assessment of suicidal intention: The Scale for Suicide Ideation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

A New Depression Scale Designed to be Sensitive to Change

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Construct and concurrent validity of the Hopkins Verbal Learning Test-revised.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

Clinical antidepressant activity of cyclazocine-a narcotic antagonist

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4157317

The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

28 October 2018

1 reference

12 December 2020

Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers

1 reference

12 December 2020

Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects

1 reference

12 December 2020

Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression

1 reference

12 December 2020

Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study

1 reference

12 December 2020

The Use of the Hamilton Rating Scale for Depression in Elderly Patients With Cognitive Impairment and Physical Illness

1 reference

12 December 2020

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

12 December 2020

beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients

1 reference

12 December 2020

Monoamine oxidase inhibitor hypertensive crisis headache and orthostatic hypotension

1 reference

12 December 2020

Identifiers

DOI

10.4088/JCP.13M08725

1 reference

31 July 2017

1 reference

31 July 2017

1 reference